This Week in Psychedelics - 9.17.21

Cannabis

• FDA And CDC Issue Warnings On Delta-8 THC Products Derived From Hemp (Marijuana Moment)

• World Anti-Doping Agency Reviews Marijuana Ban For Athletes Following Pushback On Richardson Suspension (Marijuana Moment)

• California: Lawmakers Advance Legislation Providing for Medical Cannabis Use in Hospitals (NORML)

• Runner’s High Gets New Meaning (The Wall Street Journal)

• Cannabis-Related Arrests in Virginia Decrease By 90 Percent After Legalization (High Times)

• Cannabis use linked to subtle abnormalities in speech production (PsyPost)

• Wolf administration ordered to reveal details of cannabis use as drug addiction treatment (The Philadelphia Inquirer)

• Virginia Judge Jails Woman For Using Marijuana Before Testifying Against Alleged Domestic Violence Abuser (Marijuana Moment)

• New Jersey Has Expunged A Third Of A Million Marijuana Convictions Since July (Marijuana Moment)

• New Hampshire Lawmakers Take First Step To Put Marijuana Legalization On 2022 Ballot (Marijuana Moment)

• Michigan Medical Marijuana Activists Push Back Against Alleged Corporate Effort To Restrict Home Cultivation (Marijuana Moment)

LSD

• LSD-triggered altered behaviors linked to abnormal brain communication (Medical Xpress)

• Miami student seriously injured after he jumped off roof while on LSD (Oxford Observer)

Magic Mushrooms

• First subject dosed in psilocybin trial for rare headache disorder (Pharmaphorum)

• California Activists Cleared To Collect Signatures For Psilocybin Legalization Ballot Initiative (Marijuana Moment)

• Psychedelic shroom fest gets green light from University of Michigan (MLive)

• What Happens When Dogs Eat Shrooms (DoubleBlind)

• Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment (Psilocybin Alpha)

MDMA

• Turns Out Your DNA Sticks to MDMA Caps. That Could Help Police Track Down Drug Dealers. (VICE)

• Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline (Psilocybin Alpha)

• Letter With MDMA Sent From the UK House of Commons to Prisoner (EDMTunes)

DMT

• How to Integrate Those Difficult-to-Remember DMT Experiences (Sam Woolfe)

• DMT vs. Mushrooms: Are We All Tripping On The Same Thing? (DoubleBlind)

5-MeO-DMT

• Tourists Are Now Smoking Toad Venom in Mexico’s Hipster Town Tulum (VICE)

Peyote

• Santa Cruz City Council Removes Peyote from List of Decriminalized Psychedelics (Good Times Santa Cruz)

Iboga

• Post-9/11 war vets go to Mexico to treat trauma with a psychedelic that's illegal in the US (Stars and Stripes)

Novel Psychoactive Substances

• COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs (Psilocybin Alpha)

• Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocybin Analog through Drug Discrimination Assay (Psilocybin Alpha)

Nitrous Oxide

• Nitrous-oxide: Laughing gas hits a new high in Ireland (The Irish Times)

Ketamine

• Colorado attorney general report found Aurora police racially biased and fire department administered ketamine illegally (CNN)

• Ketamine monotherapy reduces suicidal ideation in adults with depression (Healio)

• Psychable is the First Ketamine-Assisted Therapy Company to Offer a Buy One, Give One Program (GlobeNewswire)

• Sharon Osbourne Says She Underwent Ketamine Therapy After Leaving The Talk amid Controversy (People)

• Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression (Psilocybin Alpha)

Miscellaneous

• Detroit Voters Will Decide On Psychedelics Decriminalization Ballot Measure In November (Marijuana Moment)

• Michigan Lawmaker Introduces Psychedelics Decriminalization Bill (Forbes)

• Addiction specialists accused of 'massive conflict of interest' for ties to drug-testing industry (CBC)

• Tim Ferriss Gift Creates Journalism Fellowships at Berkeley’s new Center for Science of Psychedelics (UC Berkeley Graduate School of Journalism)

• Seattle bid to decriminalize psychedelics could have ‘profound’ effect on treating addiction (MyNorthwest.com)

• Psychedelic medicine comes to the VA (The Psychedelic Renaissance)

• House Could Vote On Psychedelics Research For Military And Marijuana Banking As Part Of Defense Bill (Marijuana Moment)

• Survey: U.S. College Students Drank Less, Used More Marijuana And Psychedelics During Covid-19 (Forbes)

• Congressional Panel Votes To Repeal Drug Conviction Penalty Blocking Education Tax Credit (Marijuana Moment)

• Psychedelic Use on the Rise As Gen Z Seeks To ‘Enhance Connectedness’ (VICE)

• Seattle Councilmember Says He’ll Introduce Psychedelics Decriminalization Measure By Year’s End (Marijuana Moment)

• A Renaissance for Psychedelics Could Fill a Long-Standing Treatment Gap for Psychiatric Disorders (Scientific American)

• Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy? (The Guardian)

• Fear of Death Impacts Quality of Life-How Psychedelics Can Help (Psychedelic Science Review)

• Washington State Activists Announce 2022 Drug Decriminalization Ballot Campaign (Marijuana Moment)

• Digital Psychedelia: Hidden Experience and the Challenge of Paranoia (Somatosphere)

• A Workbook for Psychedelic Integration Focuses on Life’s Big Questions (Lucid News)

• The impact and importance of psychedelic medicine (Open Access Government)

• 'Nine Perfect Strangers' is a deranged portrait of psychedelic wellness retreats (Mic)

• Understanding ‘Spiritual Emergency’ in the Context of Psychedelics (Psychedelics Today)

• What Substances Are More Likely To Be Contaminated With Fentanyl? (Lucid News)

• Discovering New Psychedelic Drugs (Reality Sandwich)

• Studying Psychedelics Pt I: North American Research (Truffle Report)

• The Therapeutic Effects of Psychedelics: 2A or Not 2A? – Part 1 (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.21.21

Cannabis

• Alabama Governor Signs Medical Marijuana Legalization Bill (Marijuana Moment)

• Montana Governor Signs Marijuana Legalization Implementation Bill (Marijuana Moment)

• Colorado Governor Signs Bill To Double Marijuana Possession Limit And Calls For Pardons Review (Marijuana Moment)

• Mississippi Supreme Court Overturns Medical Marijuana Legalization Ballot That Voters Approved (Marijuana Moment)

• Colorado bans hemp-derived delta-8 THC (Marijuana Business Daily)

• Minnesota: Lawmakers Vote to Legalize Medical Cannabis Flower (NORML)

• Texas Medical Marijuana Expansion Bill Moves Forward In Senate After Initially Stalling (Marijuana Moment)

• Louisiana Marijuana Legalization Effort Stalls After House Rejects Complementary Tax Proposal (Marijuana Moment)

• The Impact of Specific Genes on Cannabis Use Disorder (Psychedelic Science Review)

LSD

• Acid test: scientists show how LSD opens doors of perception (The Guardian)

• The Untold Story of the CIA’s MK Ultra: A Conversation with Stephen Kinzer (Los Angeles Review of Books)

• MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial (Psilocybin Alpha)

Magic Mushrooms

• A single dose of psilocybin has a lasting therapeutic effect on migraine headache, according to a new placebo-controlled study (PsyPost)

• Kristen Bell Tried Hallucinogenic Mushrooms to Help Manage Her Depression (People)

• Wake Network Successfully Completes First Legal Importation of Psilocybin Mushrooms into the U.S. (Lucid News)

• Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder (Psilocybin Alpha)

MDMA

• FDA Clears Researchers To Study MDMA Use By Therapists Being Trained In Psychedelic Medicine (Marijuana Moment)

• How MDMA, Octopuses, and Gül Dölen Reopen Minds (Chacruna)

• Narcos Scotland: The 90s rave culture in Scotland brought a deadly new trend with Ecstasy (Scottish Daily Record)

DMT

• Algernon Pharmaceuticals Receives Positive Feedback from U.S. FDA for Psychedelic Drug DMT Clinical Research Program for Stroke (Psilocybin Alpha)

• Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group (Psilocybin Alpha)

Ayahuasca

• Controversies on the Environmental Legislation on Ayahuasca in Brazil (Chacruna)

• Can Ayahuasca Help Us Communicate with the Souls of the Dead? (DoubleBlind)

Mescaline

• MindMed Announces the Approval of Mescaline Study (Psilocybin Alpha)

Peyote

• Psychedelics Advocates And Indigenous Groups Split On Decriminalizing Peyote Cactus (Marijuana Moment)

• Is Peyote the same as mescaline?: A Cultural History (Chacruna)

Salvia Divinorum

• This DEA ‘medication of concern’ may have health benefits (MD Linx)

Synthetic Cannabinoids

• Why Big Pharma Loves The Power Of Synthetic Cannabinoids (The Fresh Toast)

Ketamine

• Lamar Odom says he is using ketamine to stay sober (Page Six)

• PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

• California’s Psychedelic Decriminalization Bill Heads to Senate Floor (Truffle Report)

• Texas Senate Advances Bill To Study Healing Potential Of Psychedelics Like Psilocybin and MDMA (Marijuana Moment)

• Psychedelic Drugs Will Follow Pot’s Path to Legalization (Bloomberg)

• The future of psychedelic science (Imperial College London)

• Use of hallucinogens linked to risk seeking, emotional dysregulation in youth and college students (PsyPost)

• Confronting Inequity and Seeking Social Justice in the Psychedelic Movement (Chacruna)

• The Jacarezinho Massacre and Lethal Drug Policy Enforcement in Brazil (Filter)

• IPI: The Top Recommended Psychedelic Therapy Training (The Third Wave)

• Imagine Psychedelic Dinosaurs Tripping Daily (Reality Sandwich)

• An Investor Looks at Drug Development Strategies of Top Psychedelic Companies (Lucid News)

• Psychedelic-Assisted Psychotherapy: Reshaping Perspectives and Guiding Transformation (Psychedelic Times)

• Do Animals and Psychedelics Go Together? (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.17.20

Cannabis

• Argentina To Allow Cannabis Sales In Pharmacies And Home Cultivation (Benzinga)

• Idaho Medical Marijuana Activists Ask State For Electronic Signature Gathering Option Following Court Ruling (Marijuana Moment)

• Missouri: Kansas City Council Eliminates Local Penalties for Marijuana Possession Offenses (NORML)

• Israel passes Germany as world’s largest importer of medical cannabis flower (Marijuana Business Daily)

• The World Health Organization Says Reschedule Cannabis: Will The UN Agree? (Forbes)

• “Father of Cannabis Research” Identifies EPM301, a Cannabis Substance Stronger than THC or CBD (HealthMJ)

• Study: Cumulative Use of Cannabis Not Associated with Heart Abnormalities at Middle Age (NORML)

• CBD Is A ‘Promising’ Therapy In Treating Cocaine Misuse, Meta-Study Finds (Marijuana Moment)

• Millions of Dollars in Cannabis Vape Product Inventory Remains in Quarantine in Massachusetts (Cannabis Business Times)

• We got the inside story of the downfall of Civilized, a cannabis media startup that raised $7 million, then had to shut down after a takeover offer fell through (Business Insider)

• Survey: Majority of Health Care Professionals Endorse Cannabis Use Instead of Opioids in Chronic Pain Patients (NORML)

• The Cannabis Tax Experiment (Forbes)

• Cannabis Use Rising Among Chronic Pain Patients (NORML)

LSD

• Americans Increase LSD Use—and a Bleak Outlook for the World May Be to Blame (Scientific American)

• LSD and Psilocybin May Alleviate Cluster Headaches (Psychedelic Science Review)

• Basel: The birthplace of hallucinogenic science (BBC)

Magic Mushrooms

• New psychedelic research sheds light on why psilocybin-containing mushrooms have been consumed for centuries (PsyPost)

• The Growing Evidence for Psilocybin-Facilitated Smoking Cessation (Psychedelic Science Review)

• How to Harvest Magic Mushrooms (DoubleBlind)

• Get to Know the Beta Carbolines – Newcomers to the Science of Magic Mushrooms (Psychedelic Science Review)

• The legalization of psilocybin: Is it necessary? (Portland Tribune)

MDMA

• I’m a Paraplegic Who Used to Smuggle Ecstasy in My Wheelchair (VICE)

• How MDMA-assisted therapy could be the key to helping trauma patients (MEAWW)

• Dave Franco Did MDMA With Alison Brie To Prepare For ‘The Rental’ (ET Canada)

5-MeO-DMT

• Rains in Sonora bring with them the specimen bufo alvarius (Explica)

Iboga

• Ibogaine Can Help Us Better Understand Addiction, but Will it Solve the Opioid Crisis? (DoubleBlind)

Ketamine

• Anesthesiologist calls for 'national conversation' about forced ketamine use following McClain case (9News)

• Cost-effectiveness of esketamine for depression (Science Daily)

Miscellaneous

• It’s 2020 and White Men Still Dominate Psychedelic Conferences (Lucid News)

• We Need to Talk About MAPS Supporting The Police, The Military, and Violent White Supremacism (Psymposia)

• Lessons for Psychedelic Advocacy from the Front Lines of Cannabis Reform (Chacruna)

• To Prevent Corruption, Psychedelics Researchers Call for Ethics Guidelines (Lucid News)

• GOP Congressman Withdraws Amendment To Block D.C. Psychedelics Decriminalization (Marijuana Moment)

• The Power of Psychedelics (Scientific American)

• Magical (Psychedelic) Thinking in the Era of Climate Change and COVID-19 (Psymposia)

• The Uptight Girl’s Guide To Psychedelics (Bustle)

• AWAKN Life Sciences Partners with Drug Science in the UK (Psilocybin Alpha)

• Psychedelic journeys brought peace to this Holocaust survivor. Now he’s helping others on their own journeys. (The Jewish News of Northern California)

• How the dark web facilitates illicit drug trade across borders (MEAWW)

• Psychedelics and Canada's Regulatory Landscape (Lexology)

• The Psychedelic Renaissance: A Guide for College Students (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - June 2020

Today marks the end of the first half of 2020. It’s crazy to think that so much happened in just six months, but here we are. Between a global pandemic and worldwide protests for racial justice, it might seem like nothing else has been going on. But we can’t forget the murder hornets, toilet paper shortages, Australian bushfires, the tragic death of Kobe Bryant, and so much more that has already happened this year. If the last six months are a reliable indicator of what’s to come, we definitely need to strap in before the ride really gets going.

The psychedelic world has been busy too. This month there was a ton of psychedelic news, including scientific research findings, innovations in the psychedelic industry, and some small wins on the drug policy reform front.

Here is a slimmed-down video recap version that is available for those who prefer an easier-to-digest option:

Without further ado, let’s jump into the news:

A Follow-Up Study Demonstrates Long-Term Benefits of Treating PTSD with MDMA

First up is a story about a new follow-up study that observed impressive long-term benefits that came from treating people who had PTSD with MDMA-assisted psychotherapy.

Compiling followup data from six clinical trials, the researchers found that not only do the positive effects of the therapy hold up for more than a year after the completion of the treatment, but patients also continue to improve as time passes following the active MDMA sessions.

This study just adds more evidence to the ever-growing pile of data backing up the idea that MDMA-assisted psychotherapy is an effective treatment for PTSD.

The World’s First Psychedelic Stock Index

Although the emerging psychedelic industry is still fairly new, several businesses have gone public, which means they can actually be traded on the stock market. But for a while it has been difficult for investors, bankers, analysts, journalists, and other market participants to find out which companies are selling shares.

However, this month CFN Enterprises launched PsyIndex, a new psychedelic stock index that aggregates and tracks the market performance of the multi-billion dollar industry. If you’d like to invest in psychedelic companies, I advise you to check out PsyIndex to become familiar with the overall landscape and read The Trip Report for constructive analysis about the various players in the industry.

A Phase 2 Clinical Trial of LSD for Suicide Headaches Begins Treating Patients

Cluster headaches, also known as “suicide headaches”, are said to be one of the most painful conditions that a human can experience. The pain typically occurs on one side of the head—or above an eye—and a single attack can range from 15 minutes to 3 hours. These attacks often occur in clusters which usually last for weeks or months, and occasionally they go on for more than a year.

Anecdotal reports suggest that LSD can halt an attack in its tracks in addition to decreasing their overall frequency and intensity, but until recently there hasn’t been much modern research into using psychedelics to treat cluster headaches. However, this month a Phase 2 clinical trial investigating whether LSD is an effective treatment for the condition started treating patients.

MindMed and University Hospital Basel’s Liechti Lab are collaborating on that research in addition to other LSD studies: a Phase 2 clinical trial investigating microdosing LSD for adult ADHD and an initiative named “Project Lucy” which is going to focus on LSD experiential therapy for anxiety disorders.

Can DMT Be Used Therapeutically?

MindMed and the Liechti Lab aren’t stopping with LSD. In the final quarter of 2020 they plan to begin a Phase 1 clinical trial that will test various intravenous dosing regimens of DMT to see if the drug can be used therapeutically, with a focus on its efficacy for treating addiction. MindMed hopes that the Phase 1 study will set the stage for future potential Phase 2a proof-of-concept trials.

These two organizations aren’t the only ones interested in exploring the healing potential of DMT. The Yield Growth Corporation announced this month that its subsidiary NeonMind has filed a patent application for the therapeutic use of DMT. The company is planning to investigate whether DMT can be successfully used to treat compulsive eating disorder and other illnesses.

Spanish Porn Star Charged with Manslaughter Following 5-MeO-DMT Ritual

A Spanish porn star named Nacho Vidal was arrested and charged with manslaughter for his connection with a mysterious death following a 5-MeO-DMT ritual. Vidal was one of three people who were arrested due to their involvement with the July 2019 death of Jose Luis Abad, a Spanish fashion photographer.

Abad died after smoking the dehydrated toad venom from Colorado River toad, with contains the psychedelic compound 5-MeO-DMT. At this point we still don’t know exactly what caused the death, but it may have been due to physiological issues like respiratory depression or convulsions related to the ingestion of the venom, rather than any foul play on the behalf of Vidal or the other two people involved.

Drug Policy Activists Are Still Collecting Signatures Despite the COVID-19 Pandemic

Although some drug policy reform efforts had to put an end to their signature collection due to the global COVID-19 pandemic, not every initiative has shared the same fate.

Activists in Montana submitted 130,000 signatures to legalize cannabis and the George Floyd protests actually helped the psychedelic decriminalization campaign in Washington, D.C. It seems that the racial justice protests may have actually counteracted the loss of potential signatures caused by the pandemic.

Psilocybin and the Human Ego

A breakthrough psilocybin study uncovered a new neurochemical mechanism that enables the drug to generate psychedelic effects and dissolve the ego. The study found that psilocybin can change levels of glutamate in the human brain, which in turn determines which type of ego dissolution the patient will experience—positive or negative.

Positively-experienced ego loss is related with heightened mood and euphoria whereas negatively-experienced ego dissolution involves a loss of autonomy and self-control of thought processes. The researchers were able to predict which type of experience the patient was going through by reading the levels of glutamate in the medial prefrontal cortex and hippocampus.

And a meta-analysis of four prior studies found that psilocybin-assisted psychotherapy can engender large reductions in anxiety and depression after the completion of treatment. These benefits were also present at the six-month follow-up.

Ketamine Can Temporarily Shut Down the Brain

Another study found that high doses of ketamine are capable of temporarily shutting down the brain, which may help explain why some people report getting stuck in a “k-hole” after using the drug.

The study didn’t originally set out to study ketamine’s effects; the researchers initially wanted to find a cure for Huntington’s disease, which is a progressive disease that causes a progressive breakdown of nerve cells in the brain. And it wasn’t conducted with humans, either. Sheep were given injections of ketamine and hooked up to an EEG machine, which found that brain activity in the animals shut down entirely following the administration of ketamine. After the effects wore off, brain activity resumed, indicating that the brain can be effectively turned on and off (like a light switch) with ketamine.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 6.12.20

Cannabis

• Government announces plan to advance cannabis legalization reforms (The Times of Israel)

• Bermuda Has Officially Proposed a Framework to Legalize Adult-Use Cannabis (MERRY JANE)

• New lawsuit aims to force DEA to reschedule marijuana (Leafly)

• Effects of cannabis edibles can vary greatly based on small differences in THC dose (PsyPost)

• Kansas Medical Marijuana Bill Dies In Committee After Special Session Ends (Marijuana Moment)

• Oregon Cannabis Association Demands Portland Cannabis Tax Not Be Used on Law Enforcement (Cannabis Business Times)

• NBA Players Union Head Joins Marijuana Company As League Reportedly Suspends Drug Testing (Marijuana Moment)

• NORML Letter to NIDA: Prohibition Must Be Recognized as More Damaging than Marijuana Itself (NORML)

• Here’s how to start fixing racism in cannabis dispensaries (Leafly)

• Nevada Governor Introduces Measure To Pardon Tens Of Thousands With Marijuana Convictions (Marijuana Moment)

• South Dakota Voters Could Make Cannabis History in November (Cannabis Wire)

• Providing the Legitimacy of Cannabinoids for the Treatment of Cancer (Onco'Zine)

• Cannabis temporarily reduces severity of PTSD symptoms (News-Medical.net)

• Do Highly Potent Marijuana Concentrates Get Users More High? Not Exactly, Study Finds (Marijuana Moment)

• Ultra-low cannabis dosing: When microdosing is still too much (Leafly)

• 5 Signs of Using Cannabis Too Frequently (Psychology Today)

LSD

• Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients (PR Newswire)

Magic Mushrooms

• Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio (Globe Newswire)

• Rapid Therapeutic Explores Treatment of Anxiety Utilizing Proprietary Delivery System for Psilocybin and CBD (Globe Newswire)

• Dog rushed to vet after it eats human poo filled with magic mushrooms at beach (Daily Star)

MDMA

• Impressive long-term benefits of MDMA for treating PTSD, study reports (New Atlas)

• Is MDMA Neurotoxic? (Spirit Pharmacist)

DMT

• I Sell DMT Vape Pens So People Can 'Break Through' at Their Own Speed (VICE)

• Beyond Ayahuasca: Therapeutic Effects of N,N-Dimethyltryptamine (DMT) (Psychedelic Science Review)

• Former UFC Champion Henry Cejudo Details DMT Experience With Mike Tyson (MMA News)

Ayahuasca

• Not All Ayahuasca is Made Equal (Psychedelics Today)

• What if a Shaman Could Solve All Your Problems, in Three Days? (The New York Times)

Iboga

• Powerful psychedelic drug ibogaine could help people kick opioid addictions (Genetic Literacy Project)

Synthetic Cannabinoids

• Drug trial planned for synthetic cannabinoid coronavirus treatment (Chicago Tribune)

Nitrous Oxide

• No laughing matter: new legislation will ban the sale of nitrous oxide (DutchNews.nl)

Ketamine

• US customs officers find ketamine smuggled inside paintings of Jesus Christ (Mixmag)

• High doses of ketamine can temporarily switch off the brain (ScienceDaily)

Miscellaneous

• How the Psychedelic Movement Can Support Black Lives Matter (DoubleBlind)

• Protests Drive DC Psychedelics Decriminalization Signatures As Activists Launch Major Mailer Campaign (Marijuana Moment)

• We can no longer ignore the potential of psychedelic drugs to treat depression (The Guardian)

• Children and Psychedelics: Using Indigenous Wisdom to Examine Western Paradigms (Chacruna)

• How the War on Drugs Enables Police Brutality Against Black People (VICE)

• Colonial Shadows in the Psychedelic Renaissance (Chacruna)

• Help Decriminalize Nature Canada Petition the Canadian Government to Decriminalize Psychedelic Plants (Psychedelic Times)

• Are deep psychedelic experiences trustable? An exchange between Ken Ring and Chris Bache (Medium)

• The Power of Psychedelic Communities, Through the Lens of an Activist POTC (Lucid News)

• What Do Psychedelic Medicine Companies Owe to the Community? (Chacruna)

• Legal Highs: The Top Legal Psychoactive Plants in the US and Canada (DoubleBlind)

• Psychedelic Leadership Community Build at Psychedelic Liberty Summit (Chacruna)

• The Psychedelic Designs of Adam Nathaniel Furman (Sam Woolfe)

• Psychedelics Seek to Emulate Cannabis' Rise to Social Acceptance (New Kerala)

• PSYC Expanding Their Global Reach To Showcase Psychedelic Industry Leaders and Pioneers (Globe Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.